期刊文献+

男性HIV和HCV并发感染者HCV抗体的表达 被引量:1

Study on the HCV Antibody Response in Men HIV and HCV Concurrent Infections
下载PDF
导出
摘要 目的观察人免疫缺陷病毒(HIV)男性患者并发丙型肝炎病毒(HCV)感染后HCV抗体的表达情况,探讨影响HCV抗体表达的因素。方法选取经筛选检测最终确诊的HIV/HCV并发感染男性患者23例,每隔3个月随访一次共随访6个月。检测HIV及HCV病毒载量、CD4^+T细胞计数及HCV抗体。结果首次HCVRNA拴测阳性时78.3%的患者HCV抗体阴性;3个月后,34.8%的患者为HCV抗体阴性;6个月后,17.4%的患者HCV抗体为阴性。结论HIV并发HCV的男性感染者,HCV抗体阳性率表达较低,应早期联合核酸检测。 Objective To estimated the positive rates of antibodies and the influencing factors of antibodies expansion in Hu- man immunoddficiency virus(HIV) men infected with hepatitis C virus(HCV). Methods 23 HIV-positive patients with ear- ly HCV infection were identified. Plasma samples obtained at 3 monthly intervals(total 6 month) for routine monitoring of HIV and HCV viral load,CD4 cell counts, HCV antibodies. Results On first amplification of HCV, 78. 3 % of patients were serologically negative. Antibody detection remain seronegative 34. 8% by 3 months to 17.40% at 6 months. Conclusion The lower of HCV antibodies positive rates in HIV men with HCV should early combination of nucleic acid testing.
出处 《现代检验医学杂志》 CAS 2012年第2期99-100,103,共3页 Journal of Modern Laboratory Medicine
关键词 艾滋病病毒 丙型肝炎病毒 抗体 chronic obstructive pulmonary disease polymorphonuclear neutrophils mitochondrion
  • 相关文献

参考文献10

  • 1Fierer DS, Uriel AJ, Carriero DC, et ak Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men:a prospective cohort study[J]. J Infect Dis,2008,198(5) :683-686.
  • 2Torriani FJ, Rodriguez-Torres M, Rockstroh JK, et al. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients [J]. N Engl J Med,2004,351(5) :438-450.
  • 3Thomas DL, Astemboiski J, Rai RM, et al. The natu- ral history of hepatitis C virus infection: host, viral, and environmental factors[J ]. JAMA, 2000,284 (4) : 450-456.
  • 4丙型肝炎防治指南[J].中华流行病学杂志,2004,25(5):369-375. 被引量:65
  • 5Kinter AL, Hennessey M, Bell A,et aL CD25 (+) CD4 (+)Regulatory T Cells from the Peripheral Blood of Asymptomatic HIV-specific T Cell Immune Responses in Vitro and are Associated with Favora- ble Clinical Markers of Disease Status [J].J Exp Med, 2004,200(3) : 331-343.
  • 6Schroeter M, Zoellner B, Polywka S, et al. Prolonged time until seroconversion among hemodialysis pa- tients: the need for HCV PCR[J]. Intervirology, 2005,48(4) : 213-215.
  • 7Netski DM, Mosbruger T, Depla E, et al. Humoral immune response in acute hepatitis C virus infection [J]. Clin Infect Dis,2005,41(5):667-675.
  • 8Sulkowski MS,Thomas DL. Hepatitis C in the HIV- infected patient [J]. Clin Liver Dis, 2003,7 ( 1 ) : 179- 194.
  • 9Freeman AJ, Marinos G, French RA, et ak Immuno- pathogenesis of hepatitis C virus infection [J]. Inmmunol Cell Biol,2001,79(6) :515-536.
  • 10Borgia G,Reynaud L,Gentile I,et aL HIV and Hep- atitis C Virus:Facts and Controversies[J]. Infection, 2003,31 (4) : 232-240.

二级参考文献15

  • 1Alberti A, Benvegnu L. Management of hepatitis C. J Hepatol, 2003, 38(suppl 1)∶s1014-s1118.
  • 2Booth JCL, O'Grady J, Neuberger J. Clinical guidelines on the management of hepatitis C. Gut, 2001, 49(suppl 1)∶ s1-s21.
  • 3Camma C, Bruno S, Schepis F, et al. Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient data. Gut, 2002, 51∶864-869.
  • 4Chander G, Sulkowski MS, Jenckes MW, et al. Treatment of chronic hepatitis C: a systemic review. Hepatology,2002,36(5 suppl 1)∶s135-s144.
  • 5Di Ciommo V, Russo P, Rava L, et al. Interferon alpha in the treatment of chronic hepatitis C in children: a meta-analysis. J Viral Hepat, 2003, 10∶210-214.
  • 6Fabrizi F, Dulai G, Dixit V, et al. Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients. Aliment Pharmacol Ther, 2003, 18∶1071-1081.
  • 7Kjaergard LL, Krogsgaard K, Gluud C. Interferon alfa with or without ribavirin for chronic hepatitis C: systematic review of randomised trials. BMJ, 2001, 323∶1151-1155.
  • 8National Institute of Health Consensus Development Conference Panel Statement. Management of hepatitis C. Hepatology, 2002, 36(5 suppl 1)∶s3-s20.
  • 9Papatheodoridis GV, Papadimitropoulos VC, Hadziyannis SJ. Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a meta-analysis. Aliment Pharmacol Ther, 2001, 15∶689-698.
  • 10Poynard T, McHutchison J, Davis GL, et al. Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C. Hepatology, 2000, 32∶1131-1137.

共引文献64

同被引文献9

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部